Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.12.18
Views: 475

Dr Jennifer Woyach - The Ohio State University Comprehensive Cancer Center, Columbus, USA

Dr Jennifer Woyach gives a press conference at ASH 2018 about results from a trial of ibrutinib vs chemoimmunotherapy in older patients with chronic lymphocytic leukaemia.

Watch her interview with ecancer here.

Read the article about this work here

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation